Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice

Abbott, 1991, Morphine-6-glucuronide contributes to rewarding effects of opiates, Life Sci, 48, 1157, 10.1016/0024-3205(91)90453-I Adinoff, 2004, Neurobiologic processes in drug reward and addiction, Harv Rev Psychiatry, 12, 305, 10.1080/10673220490910844 Allen, 2006, Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease, Am J Physiol Lung Cell Mol Physiol, 291, L1005, 10.1152/ajplung.00174.2006 Badia-Elder, 2008, The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats, Alcohol Clin Exp Res, 32, 1380, 10.1111/j.1530-0277.2008.00713.x Bals-Kubik, 1993, Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats, J Pharmacol Exp Ther, 264, 489 Beck, 2005, Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats, Biochem Biophys Res Commun, 332, 859, 10.1016/j.bbrc.2005.05.029 Bedingfield, 1998, Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity, Pharmacol Biochem Behav, 61, 291, 10.1016/S0091-3057(98)00092-6 Bernier, 2006, Structure–function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I, J Biol Chem, 281, 24704, 10.1074/jbc.M603691200 Bozarth, 1987, Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats, Brain Res, 414, 77, 10.1016/0006-8993(87)91327-8 Brockwell, 1991, Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion, Pharmacol Biochem Behav, 38, 513, 10.1016/0091-3057(91)90006-N Brown, 1993, Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference, Psychopharmacology (Berl), 113, 123, 10.1007/BF02244344 Calcagnetti, 1995, Blockade of cocaine-induced conditioned place preference: relevance to cocaine abuse therapeutics, Life Sci, 56, 475, 10.1016/0024-3205(94)00414-N Calcagnetti, 1994, Nicotine place preference using the biased method of conditioning, Prog Neuropsychopharmacol Biol Psychiatry, 18, 925, 10.1016/0278-5846(94)90108-2 Chang, 2005, Structure–activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor, Regul Pept, 130, 116, 10.1016/j.regpep.2005.04.005 Cline, 2007, Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus), Comp Biochem Physiol A Mol Integr Physiol, 148, 657, 10.1016/j.cbpa.2007.08.016 Cowen, 1999, The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption, Prog Neuropsychopharmacol Biol Psychiatry, 23, 1171, 10.1016/S0278-5846(99)00060-3 Cunningham, 2003, Apparatus bias and place conditioning with ethanol in mice, Psychopharmacology (Berl), 170, 409, 10.1007/s00213-003-1559-y D’Amato, 2007, Neuropeptide S receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease, Gastroenterology, 133, 808, 10.1053/j.gastro.2007.06.012 Duvauchelle, 1992, Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward, Brain Res, 576, 104, 10.1016/0006-8993(92)90614-F Fenu, 2006, Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression, Psychopharmacology (Berl), 187, 143, 10.1007/s00213-006-0415-2 Fudala, 1985, Pharmacologic characterization of nicotine-induced conditioned place preference, Pharmacol Biochem Behav, 22, 237, 10.1016/0091-3057(85)90384-3 Grabus, 2006, Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists, Psychopharmacology (Berl), 184, 456, 10.1007/s00213-006-0305-7 Hall, 2001, Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice, Psychopharmacology (Berl), 154, 43, 10.1007/s002130000622 Herz, 1997, Endogenous opioid systems and alcohol addiction, Psychopharmacology (Berl), 129, 99, 10.1007/s002130050169 Hiroi, 1991, The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas, Brain Res, 552, 141, 10.1016/0006-8993(91)90672-I Hiroi, 1991, The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference, J Neurosci, 11, 2107, 10.1523/JNEUROSCI.11-07-02107.1991 Hyman, 2006, Neural mechanisms of addiction: the role of reward-related learning and memory, Annu Rev Neurosci, 29, 565, 10.1146/annurev.neuro.29.051605.113009 Jaeger, 1996, Separate neural substrates mediate the motivating and discriminative properties of morphine, Behav Neurosci, 110, 181, 10.1037/0735-7044.110.1.181 Koob, 1998, Neuroscience of addiction, Neuron, 21, 467, 10.1016/S0896-6273(00)80557-7 Kotlinska, 2007, (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats, Peptides, 28, 2235, 10.1016/j.peptides.2007.08.006 Lage, 2006, Caffeine treatment regulates neuropeptide S system expression in the rat brain, Neurosci Lett, 410, 47, 10.1016/j.neulet.2006.09.064 Lage, 2007, Nicotine treatment regulates neuropeptide S system expression in the rat brain, Neurotoxicology, 28, 1129, 10.1016/j.neuro.2007.06.003 Larsson, 2004, Neurochemical and behavioral studies on ethanol and nicotine interactions, Neurosci Biobehav Rev, 27, 713, 10.1016/j.neubiorev.2003.11.010 Mamoon, 1995, Comparative rewarding properties of morphine and butorphanol, Brain Res Bull, 38, 507, 10.1016/0361-9230(95)02022-J Marchand, 2006, A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice, Peptides, 27, 964, 10.1016/j.peptides.2005.07.023 Nader, 1997, Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area, J Neurosci, 17, 383, 10.1523/JNEUROSCI.17-01-00383.1997 Niimi, 2006, Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats, Endocrine, 30, 75, 10.1385/ENDO:30:1:75 Okamura, 2008, Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor, J Pharmacol Exp Ther, 325, 893, 10.1124/jpet.107.135103 Okamura, 2007, Gender-specific association of a functional coding polymorphism in the neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder, Prog Neuropsychopharmacol Biol Psychiatry, 31, 1444, 10.1016/j.pnpbp.2007.06.026 Olmstead, 1997, The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites, Behav Neurosci, 111, 1324, 10.1037/0735-7044.111.6.1324 Philibin, 2005, Differential behavioral responses to nicotine in Lewis and Fischer-344 rats, Pharmacol Biochem Behav, 80, 87, 10.1016/j.pbb.2004.10.009 Pulkkinen, 2006, Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses, Hum Mol Genet, 15, 1667, 10.1093/hmg/ddl090 Reinscheid, 2007, Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods, Peptides, 28, 830, 10.1016/j.peptides.2007.01.008 Reinscheid, 2008, Neuropeptide S: anatomy, pharmacology, genetics and physiological functions, Results Probl Cell Differ, 46, 145, 10.1007/400_2007_051 Reinscheid, 2005, Neuropeptide S as a novel arousal promoting peptide transmitter, FEBS J, 272, 5689, 10.1111/j.1742-4658.2005.04982.x Reinscheid, 2005, Neuropeptide S and its receptor: a newly deorphanized G protein-coupled receptor system, Neuroscientist, 11, 532, 10.1177/1073858405276405 Reinscheid, 2005, Neuropeptide S: a new player in the modulation of arousal and anxiety, Mol Interv, 5, 42, 10.1124/mi5.1.8 Reinscheid, 2005, Pharmacological characterization of human and murine neuropeptide S receptor variants, J Pharmacol Exp Ther, 315, 1338, 10.1124/jpet.105.093427 Rizzi, 2008, Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice, Br J Pharmacol, 154, 471, 10.1038/bjp.2008.96 Roth, 2006, Structure–activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation, J Biol Chem, 281, 20809, 10.1074/jbc.M601846200 Sellings, 2003, Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core, J Neurosci, 23, 6295, 10.1523/JNEUROSCI.23-15-06295.2003 Smith, 2006, Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake, Endocrinology, 147, 3510, 10.1210/en.2005-1280 Spanagel, 1999, The dopamine hypothesis of reward: past and current status, Trends Neurosci, 22, 521, 10.1016/S0166-2236(99)01447-2 Spina, 2006, Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition, Psychopharmacology (Berl), 184, 447, 10.1007/s00213-005-0211-4 Tzschentke, 1998, Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues, Prog Neurobiol, 56, 613, 10.1016/S0301-0082(98)00060-4 Tzschentke, 2007, Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade, Addict Biol, 12, 227, 10.1111/j.1369-1600.2007.00070.x Vendelin, 2005, Characterization of GPRA, a novel G protein-coupled receptor related to asthma, Am J Respir Cell Mol Biol, 33, 262, 10.1165/rcmb.2004-0405OC White, 1993, Acquisition of a spatial conditioned place preference is impaired by amygdala lesions and improved by fornix lesions, Behav Brain Res, 55, 269, 10.1016/0166-4328(93)90122-7 Xu, 2007, Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain, J Comp Neurol, 500, 84, 10.1002/cne.21159 Xu, 2004, Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects, Neuron, 43, 487, 10.1016/j.neuron.2004.08.005 Zollner, 2007, Opioids, Handb Exp Pharmacol, 31 Zvartau, 1986, Reinforcing, but no analgesic, effect of opioid stimulation of the ventral tegmental area, Biull Eksp Biol Med, 102, 172, 10.1007/BF00836197